DSD. V. Shkolnikova

D. V. Shkolnikova

*This is an algorithmically generated author record based on publicly available information.

D. V. Shkolnikova has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Molecular genetics of neurodevelopmental disorders in Ukrainian children

    by Y.R. Grechanin, A.L. Fadieieva, D.V. Shkolnikova

    Neurodevelopmental disorders make a significant contribution to pediatric pathologies. This group of diseases varies symptomatically and has various underlying molecular reasons, which result in the necessity of personalized diagnostic and treatment protocols. Aim - to detect metabolic pathways and molecular markers potentially contributing to the development of the pathological phenotype in pediatric patients with neural pathology. Materials and methods. Selection of the patient’s cohort for the pilot study was done during consultations provided by pediatricians, geneticists, and neurologists following principles of an interdisciplinary approach in diagnostic and management of children with developmental abnormalities. Further analysis of detected DNA variations, along with structural and functional predictions, was done using the SNP-NEXUS tool. Results. The work presented in this manuscript enabled the identification of all detected genomic variations that may be associated with the chosen clinical phenotype in the small cohort of patients. Further functional enrichment analysis allowed us to identify various biological cellular processes that may be affected by the identified genomic alterations. Particularly, we found metabolic pathways with high enrichment score for possibly pathogenic and probably pathogenic amino acid substitutions in proteins, with lipid metabolism having the highest enrichment score. Conclusions. Predictive and functional enrichment analysis of SNV (Single Nucleotide Variation) patterns detected by DNA sequencing on a small cohort of pediatric patients with neurodevelopmental pathology allowed us to identify cellular processes and proteins that potentially play a role in neural pathology. Further investigation in a higher number of patients and search for statistically significant associations of the preselected targets with the phenotype may help to improve the diagnostic and treatment approach for the selected pathology. The study was conducted in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Local Ethics Committee of the institution. Informed parental consent was obtained for participation in the study. The authors declare no conflict of interest.

  • A clinical case of telomeropathy with heterozygous RTEL1 variant c.3791G>A (p.Arg1264His): discussion of bone marrow transplantation and multisystem management

    by Olena Grechanina, Valerii Miasoiedov, Yurii Sadovnychenko, Daria Shkolnikova, Yulia Kupriyanchuk, Yaroslav Grechanyn, Olena Klimova, Andrii Volyansky, Tetyana Frolova, Ludmila Molodan, et al.

    Telomeropathies show multisystem phenotypes from dyskeratosis to severe neurological forms caused by genetic variation in genes of the telomerase complex and related proteins, in particular RTEL1. The aim of the study was to demonstrate a personal observation of a young adult with telomeropathy and multisystem manifestations associated with RTEL1 variant c.3791G>A (p.Arg1264His) and to analyze the treatment strategy including bone marrow transplantation. Materials and methods. The article presents the personal observation of a patient diagnosed with telomeropathy during his dynamic monitoring by a multidisciplinary team from 2020 to 2025. Common blood analyses, serum amino acid spectrum, serum homocysteine, immunogram, ultrasound investigation, computer tomography, genetic testing were performed on the patient. Results. The patient complained of episodic fever, associated with rash, skin manifestations (hyperkeratosis, telangiectasias), arthralgias and persistent viral infections. Hepato-splenomegaly, cerebellar ataxia, thrombocytopenia were revealed during examination. Computed tomography showed signs of moderate bronchiectasis of small bronchi in the middle and lower parts of the lungs. Genetic testing identified the heterozygous variant RTEL1 mutation c.3791G>A (p.Arg1264His) and CNV affecting duplication of DOCK8 gene (exons 1-26, CN≈3) as a variant of uncertain significance (VUS). The patient was diagnosed with teomeropathy. Conclusions. We suggest a personalized approach to bone marrow transplantation in the treatment of telomeropathy, considering not only clinical diagnosis but also individual patient characteristics, hematological, immunological and metabolic profiles.

  • A CLINICAL CASE OF HOYERALL-HREIDARSSON SYNDROME MANIFESTING IN ADOLESCENCE

    by O. Ya. Grechanina, Ya. R. Grechanyn, D. V. Shkolnikova, Yu. M. Kupriyanchuk, O. M. Klimova